InsiderTrades

Form 4 for RARE Ultragenyx Pharmaceutical Inc.

Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001209191-23-016045 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-03-03 2023-03-01 RARE Huizenga Theodore Alan SVP, CAO A - Grant $0.00 +7,590 23.1K +49% $0
D 2023-03-03 2023-03-01 RARE Huizenga Theodore Alan SVP, CAO D - Sale to Iss $45.65 -1,333 21.7K -6% -$60.9K
D 2023-03-03 2023-03-01 RARE Huizenga Theodore Alan SVP, CAO S - Sale $45.65 -100 23.0K -0.4% -$4,565
D 2023-03-03 2023-03-01 RARE Huizenga Theodore Alan SVP, CAO A - Grant $0.00 +10.1K 10.1K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-01 A A 7,590 $0.00 23,148 D — — (F1) Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.
2 Common Common Stock 2023-03-01 D D 1,333 $45.65 21,715 D — — (F3) Shares were acquired upon the partial vesting of a previously reported RSU and were sold to permit the cash value of the awards to be credited to the deferred compensation plan account of the Reporting Person. (F4) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
3 Common Common Stock 2023-03-01 S D 100 $45.65 23,048 D — — (F2) Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
4 Derivative Stock Option (Right to Buy) 2023-03-01 A A 10,120 $0.00 10,120 D $45.65 · — to 2033-03-01 10,120 Common Stock (F5) On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.